Index by author

January 1, 2005; Volume 46,Issue 1 suppl

Clinical Practice of Molecular Radiotherapy - Steven M. Larson and Eric P. Krenning, Guest Editors

A

  1. Adelstein, S. James

    1. Radiobiologic Principles in Radionuclide Therapy
      Amin I. Kassis and S. James Adelstein
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 4S-12S;

  2. Anthony, Lowell B.

    1. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;

B

  1. Bakker, Willem H.

    1. Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma
      Jaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
    2. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;

  2. Barone, Raffaella

    1. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
    2. Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
      Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
    3. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

  3. Bernard, Bert F.

    1. Combination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin Analogs
      Marion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;

  4. Bodei, Lisa

    1. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;

  5. Borson-Chazot, Françoise

    1. Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
      Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
    2. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

  6. Breeman, Wout A.P.

    1. Combination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin Analogs
      Marion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;

  7. Buchsbaum, Donald J.

    1. Radiotargeted Gene Therapy
      Donald J. Buchsbaum, Tandra R. Chaudhuri and Kurt R. Zinn
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 179S-186S;

C

  1. Capello, Astrid

    1. Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides
      Leo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van Hagen
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;

  2. Chaudhuri, Tandra R.

    1. Radiotargeted Gene Therapy
      Donald J. Buchsbaum, Tandra R. Chaudhuri and Kurt R. Zinn
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 179S-186S;

  3. Chauvin, Franck

    1. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

  4. Cheung, Nai-Kong V.

    1. Antibody-Based Targeted Radiation to Pediatric Tumors
      Shakeel Modak and Nai-Kong V. Cheung
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 157S-163S;

  5. Chinol, Marco

    1. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;

D

  1. de Herder, Wouter W.

    1. Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
      Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;

  2. de Jong, Marion

    1. Combination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin Analogs
      Marion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
    2. Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides
      Leo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van Hagen
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
    3. Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
      Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
    4. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;

  3. Divgi, Chaitanya

    1. Current Status of Therapy of Solid Tumors
      Yuliya S. Jhanwar and Chaitanya Divgi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 141S-150S;

F

  1. Farahati, Jamshid

    1. Radiosynovectomy in Rheumatology, Orthopedics, and Hemophilia
      Peter Schneider, Jamshid Farahati and Christoph Reiners
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 48S-54S;

G

  1. Gogou, Lida

    1. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

  2. Goldenberg, David M.

    1. Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies
      Robert M. Sharkey and David M. Goldenberg
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 115S-127S;

H

  1. Haberkorn, Uwe

    1. 68Ga-Labeled Peptides in Tumor Imaging
      Helmut R. Maecke, Michael Hofmann and Uwe Haberkorn
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 172S-178S;

  2. Hofland, Leo J.

    1. Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides
      Leo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van Hagen
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;

  3. Hofmann, Michael

    1. 68Ga-Labeled Peptides in Tumor Imaging
      Helmut R. Maecke, Michael Hofmann and Uwe Haberkorn
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 172S-178S;

J

  1. Jamar, Francois

    1. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;

  2. Jamar, François

    1. Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
      Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
    2. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

  3. Jhanwar, Yuliya S.

    1. Current Status of Therapy of Solid Tumors
      Yuliya S. Jhanwar and Chaitanya Divgi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 141S-150S;

  4. Jurcic, Joseph G.

    1. The Promise of Targeted α-Particle Therapy
      Deborah A. Mulford, David A. Scheinberg and Joseph G. Jurcic
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 199S-204S;

K

  1. Kassis, Amin I.

    1. Radiobiologic Principles in Radionuclide Therapy
      Amin I. Kassis and S. James Adelstein
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 4S-12S;

  2. Kooij, Peter P.M.

    1. Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma
      Jaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
    2. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;

  3. Krenning, Eric P.

    1. Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma
      Jaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
    2. Combination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin Analogs
      Marion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
    3. Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides
      Leo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van Hagen
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
    4. A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy
      Steven M. Larson and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 1S-3S;
    5. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
    6. Candidates for Peptide Receptor Radiotherapy Today and in the Future
      Jean Claude Reubi, Helmut R. Mäcke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 67S-75S;
    7. Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
      Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
    8. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
    9. Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
      Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
    10. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

  4. Kvols, Larry K.

    1. Radiation Sensitizers: A Selective Review of Molecules Targeting DNA and non-DNA Targets
      Larry K. Kvols
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 187S-190S;
    2. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
    3. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
    4. Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
      Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
    5. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

  5. Kwekkeboom, Dik J.

    1. Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma
      Jaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
    2. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
    3. Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
      Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
    4. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;

L

  1. Larson, Steven M.

    1. A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy
      Steven M. Larson and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 1S-3S;

  2. Lasher, Janet

    1. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;

  3. Lewington, Val J.

    1. Bone-Seeking Radionuclides For Therapy
      Val J. Lewington
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 38S-47S;

M

  1. Mäcke, Helmut R.

    1. Candidates for Peptide Receptor Radiotherapy Today and in the Future
      Jean Claude Reubi, Helmut R. Mäcke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 67S-75S;

  2. Maecke, Helmut R.

    1. 68Ga-Labeled Peptides in Tumor Imaging
      Helmut R. Maecke, Michael Hofmann and Uwe Haberkorn
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 172S-178S;
    2. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;

  3. Menda, Yusuf

    1. MIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic Use
      Farzana D. Pashankar, M. Sue O’Dorisio and Yusuf Menda
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 55S-61S;

  4. Modak, Shakeel

    1. Antibody-Based Targeted Radiation to Pediatric Tumors
      Shakeel Modak and Nai-Kong V. Cheung
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 157S-163S;

  5. Mueller-Brand, Jan

    1. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;

  6. Mulford, Deborah A.

    1. The Promise of Targeted α-Particle Therapy
      Deborah A. Mulford, David A. Scheinberg and Joseph G. Jurcic
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 199S-204S;

O

  1. O’Dorisio, M. Sue

    1. MIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic Use
      Farzana D. Pashankar, M. Sue O’Dorisio and Yusuf Menda
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 55S-61S;

  2. O’Dorisio, Thomas M.

    1. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;

P

  1. Paganelli, Giovanni

    1. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;

  2. Pashankar, Farzana D.

    1. MIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic Use
      Farzana D. Pashankar, M. Sue O’Dorisio and Yusuf Menda
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 55S-61S;

  3. Pauwels, Stanislas

    1. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
    2. Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
      Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
    3. Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
      Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
    4. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

  4. Pauwels, Stanislas A.

    1. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;

R

  1. Reiners, Christoph

    1. Radiosynovectomy in Rheumatology, Orthopedics, and Hemophilia
      Peter Schneider, Jamshid Farahati and Christoph Reiners
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 48S-54S;

  2. Reubi, Jean-Claude

    1. Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
      Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;

  3. Reubi, Jean Claude

    1. Candidates for Peptide Receptor Radiotherapy Today and in the Future
      Jean Claude Reubi, Helmut R. Mäcke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 67S-75S;

  4. Robbins, Richard J.

    1. The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma
      Richard J. Robbins and Martin J. Schlumberger
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 28S-37S;

S

  1. Scheinberg, David A.

    1. The Promise of Targeted α-Particle Therapy
      Deborah A. Mulford, David A. Scheinberg and Joseph G. Jurcic
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 199S-204S;

  2. Schlumberger, Martin J.

    1. The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma
      Richard J. Robbins and Martin J. Schlumberger
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 28S-37S;

  3. Schneider, Peter

    1. Radiosynovectomy in Rheumatology, Orthopedics, and Hemophilia
      Peter Schneider, Jamshid Farahati and Christoph Reiners
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 48S-54S;

  4. Sgouros, George

    1. Dosimetry of Internal Emitters
      George Sgouros
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 18S-27S;

  5. Sharkey, Robert M.

    1. Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies
      Robert M. Sharkey and David M. Goldenberg
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 115S-127S;

T

  1. Teunissen, Jaap J.M.

    1. Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma
      Jaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;

V

  1. Valkema, Roelf

    1. Combination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin Analogs
      Marion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
    2. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
      Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
    3. Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
      Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
    4. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
    5. Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
      Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
    6. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

  2. van Dongen, Guus A.

    1. The Promise of Immuno-PET in Radioimmunotherapy
      Iris Verel, Gerard W.M. Visser and Guus A. van Dongen
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 164S-171S;

  3. van Eijck, Casper H.J.

    1. Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
      Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;

  4. van Hagen, Martin P.

    1. Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides
      Leo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van Hagen
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;

  5. Verel, Iris

    1. The Promise of Immuno-PET in Radioimmunotherapy
      Iris Verel, Gerard W.M. Visser and Guus A. van Dongen
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 164S-171S;

  6. Visser, Gerard W.M.

    1. The Promise of Immuno-PET in Radioimmunotherapy
      Iris Verel, Gerard W.M. Visser and Guus A. van Dongen
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 164S-171S;

W

  1. Wahl, Richard L.

    1. Tositumomab and 131I Therapy in Non-Hodgkin’s Lymphoma
      Richard L. Wahl
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 128S-140S;

  2. Walrand, Stephan

    1. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
      Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;

  3. Walrand, Stéphan

    1. Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
      Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
    2. Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
      Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;

Z

  1. Zalutsky, Michael R.

    1. Current Status of Therapy of Solid Tumors: Brain Tumor Therapy
      Michael R. Zalutsky
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 151S-156S;

  2. Zinn, Kurt R.

    1. Radiotargeted Gene Therapy
      Donald J. Buchsbaum, Tandra R. Chaudhuri and Kurt R. Zinn
      Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 179S-186S;
Back to top

In this issue

Journal of Nuclear Medicine: 46 (1 suppl)
Journal of Nuclear Medicine
Vol. 46, Issue 1 suppl
January 1, 2005
Sign up for alerts